Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

11
June Cha staff
June Cha
June Cha is a policy director at FasterCures, MI Health.
Apr 23, 2024
FasterCures Quarterly Update: July 2023 article
FasterCures Quarterly Update: July 2023
In This Issue: Convenings Recap Policy Updates FasterCures in the Media FasterCures in the Communit
y
Jul 13, 2023
FasterCures Quarterly Update—April 2024 article
FasterCures Quarterly Update—April 2024
In This Newsletter New FasterCures Team Member Policy Updates Events and Convenings Recap FasterCur
es in the Community
Apr 11, 2024
MI Health landing page
MI Health
MI Health bridges innovation gaps across the health and health-care continuum. We advance whole-pers
on health throughout the life span by improving healthy aging, public health, biomedical science, and food systems., Future of Health Summit Panels The Milken Institute Future of Health Summit brought together hundreds of leaders from across sectors to discuss critical issues and solutions within reach for , ,
Apr 23, 2024
The 2024-2025 FasterCures LeadersLink Cohort article
The 2024-2025 FasterCures LeadersLink Cohort
The 2024–2025 FasterCures’ LeadersLink program cohort has been carefully selected from a highly comp
etitive pool of candidates.
Apr 23, 2024
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
Jul 21, 2023
TRAIN Newsletter — April 2024 article
TRAIN Newsletter — April 2024
TRAIN eNews is delivered directly to organizations participating in The Research Acceleration and In
novation Network (TRAIN).
Apr 22, 2024
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561 article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth Associate Commissioner for Policy Food and Drug Administration 5630 Fishers Lane, Rm.
1061 Rockville, MD 20852 Dear Ms. Roth,
Apr 29, 2024
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
Apr 3, 2024
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically 
Jul 10, 2023